Press Releases

Below you will find the latest press releases from Evolva. You are also welcome to dive into the archive and browse our press releases from there as well:

Latest Press Releases

Reinach, Switzerland, 8 April 2014 – Evolva Holding SA (SIX: EVE) today announces its financial results for the period 1 January to 31 December 2013. The annual report is available on Evolva’s website.

Reinach, Switzerland, 5 March 2014 - Evolva Holding SA (SIX: EVE, “Evolva” or the “Company”) announces that Credit Suisse, who is acting as Sole Bookrunner in the private placement announced on 25 February 2014, has exercised in full the over-allotment option of 4,050,000 shares at the placement price of CHF 1.37 per share.

Reinach, Switzerland, 4 March 2014 – Evolva Holding SA (SIX: EVE) today announces that Roquette Frères SA (Roquette) has confirmed that Evolva has achieved the second R&D milestone in their collaboration.

Reinach, Switzerland, 26 February 2014 - Evolva Holding SA (SIX: EVE, “Evolva” or the “Company”) has successfully completed its placement of shares which was announced yesterday. Evolva has sold 27,000,000 new shares via an accelerated bookbuild process

Reinach, Switzerland, 25 February 2014 - Evolva Holding SA reports preliminary, unaudited financial results for 2013 and announces launch of share placement

Reinach, Switzerland, 10 February 2014 - Evolva Holding SA (SIX: EVE) announced that it has signed a collaboration agreement with L’Oréal for the co-development of novel biosynthetic production routes for an undisclosed ingredient with broad applications in the cosmetics industry.

Reinach, Switzerland, 9 January 2014 – Evolva Holding SA (SIX:EVE) has appointed BNY Mellon, the global leader in investment management and investment services, to set up a Level-1 American Depositary Receipt (ADR) programme.

Contact Information

Evolva SA
Duggingerstrasse 23
CH-4153 Reinach
Switzerland
Tel: +41 61 485 2000
Fax: +41 61 485 2001
Evolva A/S
Lersoe Parkallé 42-44
DK-2100 Copenhagen OE
Denmark
Tel: +45 35 200 230
Fax: +45 35 200 231
Evolva Biotech Private Limited
401 - 405, 4th Floor
Ticel Bio Park Ltd
Taramani Road, Taramani
Chennai 600 113
Tamil Nadu, India
Tel: +91 44 4297 1050
Fax: +91 44 4297 1060
Evolva, Inc. (Evolva USA)
2440 Embarcadero Way
Palo Alto
CA 94303
USA
Tel: +1 650 856 2436
Fax: +1 650 856 7950

General Enquiries: info@evolva.com • Business Enquiries: busdev@evolva.com • India Enquiries: info_india@evolva.com